3 results match your criteria: "Madrid Public Health Institute[Affiliation]"
Seroprevalence of antibodies to varicella-zoster virus in Madrid (Spain) in the absence of vaccination.
Cent Eur J Public Health
March 2008
Epidemiology Department, Madrid Public Health Institute, Madrid, Spain.
Objective: to ascertain the seroprevalence of antibodies to varicella-zoster virus in the Madrid population prior to the introduction of vaccination.
Study Design: Cross-sectional antibody seroprevalence study.
Population: persons aged 2 to 40 years in Madrid.
Varicella and herpes zoster in Madrid, based on the Sentinel General Practitioner Network: 1997-2004.
BMC Infect Dis
June 2007
Department of Epidemiology, Madrid Public Health Institute, Julián Camarillo 4B, Madrid, Spain.
Background: Varicella (chickenpox) is the primary disease caused by varicella-zoster virus. It is extremely contagious and is frequent in children. Indeed, in the absence of vaccination, a high proportion of the population is liable to contract it.
View Article and Find Full Text PDFTime trend and age-period-cohort effect on kidney cancer mortality in Europe, 1981-2000.
BMC Public Health
May 2006
Department of Epidemiology, Madrid Public Health Institute, Julián Camarillo 4B, 28037 Madrid, Spain.
Background: The incorporation of diagnostic and therapeutic improvements, as well as the different smoking patterns, may have had an influence on the observed variability in renal cancer mortality across Europe. This study examined time trends in kidney cancer mortality in fourteen European countries during the last two decades of the 20th century.
Methods: Kidney cancer deaths and population estimates for each country during the period 1981-2000 were drawn from the World Health Organization Mortality Database.